HIV-1 Clinical Isolates with the E138A Substitution in Reverse Transcriptase Show Full Susceptibility to Emtricitabine and Other Nucleoside Reverse Transcriptase Inhibitors |
| |
Authors: | Danielle P. Porter Rima Kulkarni Kirsten L. White |
| |
Affiliation: | Gilead Sciences, Inc., Foster City, California, USA |
| |
Abstract: | |
| |
Keywords: | |
|
|